Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Laminin (925-933) Protocol and QC Guide
2026-09-21
Laminin (925-933) is a defined Laminin B1 chain peptide for controlled cell attachment, migration, and chemotaxis workflows. This guide covers preparation, assay setup, quality controls, and interpretation boundaries; it is for research use only and should not be treated as a diagnostic, therapeutic, or universally validated metastasis model reagent.
-
HBTU Workflows for Precision Peptide Synthesis
2026-09-21
HBTU supports rapid, mild peptide bond formation for solid-phase construction of complex enzyme-responsive sequences. This workflow connects carboxylic acid activation with practical assay design for zwitterionic peptide assemblies, while clearly separating synthesis performance from biological and translational claims.
-
NEDD4L–PRMT5 in Colorectal Liver Metastasis
2026-09-20
This 2025 study identifies the HECT E3 ligase NEDD4L as a suppressor of colorectal cancer liver metastasis and defines PRMT5 as its degradation substrate. The findings connect NEDD4L-dependent PRMT5 turnover with reduced AKT1 arginine methylation and inhibition of AKT/mTOR signaling, providing a mechanistic framework for studying metastatic colonization.
-
Selective Autophagy and IRF3 Stability in Antiviral Immunity
2026-09-19
The reference study identifies a CALCOCO2/NDP52-dependent selective autophagy pathway that degrades IRF3 in response to increasing viral burden. It also shows that PSMD14 preserves IRF3 by removing K27-linked ubiquitin chains at lysine 313, defining a regulatory balance between type I interferon activation and immune suppression.
-
Beyond Detection: V5 Tags for Dynamic Protein Biology
2026-09-18
The V5 Epitope Tag Peptide is more than a Western blot reagent: it is a defined antigenic control that can strengthen recombinant protein workflows and help researchers connect endpoint immunoassays with dynamic antibody-based imaging. This article examines the mechanistic rationale, validation strategy, translational value, and practical limits of using the GKPIPNPLLGLDST peptide.
-
c-Myc Peptide: Tag-Displacement Workflows
2026-09-18
Use the c-Myc tag peptide as a controlled competitor to test anti-c-Myc antibody specificity, release tagged fusion proteins, and improve immunoassay troubleshooting. This guide connects practical peptide handling with the reference study’s broader lesson: transcription-factor measurements become more informative when stability, binding, and pathway context are separated experimentally.
-
Gly-Gly-Phe-Gly (GGFG) Peptide Guide
2026-09-17
Gly-Gly-Phe-Gly is a short, flexible peptide spacer used in research on drug conjugation, antibody engineering, and biomaterial design. The GGFG peptide has a reported molecular weight of 336.34 g/mol, 98% purity, and storage requirements that favor sealed, light- and moisture-protected handling at −20 °C.
-
gamma-Glu-Cys (γ-Glu-Cys) Practical Guide
2026-09-17
gamma-Glu-Cys (γ-Glu-Cys) provides a defined L-glutathione biosynthesis intermediate for glutathione synthetase enzyme assay development, glutathione metabolism research, and related peptide workflows. It is intended for scientific research only; it should not be used for diagnostic, therapeutic, or medical applications, and fresh solutions should be used promptly.
-
FLAG tag Peptide: Practical Purification Workflows
2026-09-16
Build cleaner recombinant protein purification, detection, and functional-assay workflows around the FLAG tag Peptide. Learn how gentle competitive elution, enterokinase-compatible construct design, and orthogonal validation can improve work with sensitive multisubunit proteins.
-
Cell Cycle Assay Kit for Flow Cytometry
2026-09-16
Turn DNA content into an actionable map of G0/G1, S, and G2/M populations while tracking sub-G1 loss associated with apoptosis. This PI/RNase A workflow is especially useful for treatment-response studies in aggressive leukemia models, where cell-cycle redistribution should be interpreted alongside molecular mechanism.
-
HBTU: Reliable Peptide Coupling for Cell Assays
2026-09-15
This practical guide explains how HBTU supports reproducible peptide and probe preparation upstream of cell viability, proliferation, and cytotoxicity assays. It evaluates SKU A7023 from APExBIO across handling, compatibility, optimization, interpretation, and vendor-selection considerations without overstating evidence.
-
Genistein in Mechanostress Cancer Assays
2026-09-15
Genistein offers a pharmacological lens for separating growth-factor signaling from cytoskeleton-dependent autophagy under compression. This article integrates kinase inhibition, assay controls, and cancer chemoprevention applications into a practical experimental framework.
-
3X FLAG Peptide for Protein Workflows
2026-09-14
The 3X (DYKDDDDK) Peptide adds a high-visibility, competition-ready reagent to FLAG-based detection, purification, ELISA, and crystallization workflows. Its hydrophilic triple-repeat design is especially useful when assay sensitivity, metal compatibility, or tag accessibility is limiting.
-
Topotecan (SKF104864) Workflow for Cancer Research
2026-09-14
Topotecan combines a defined topoisomerase I mechanism with practical utility in glioma, stem-cell, and pediatric tumor workflows. This guide translates pharmacology into concentration selection, assay design, combination planning, and troubleshooting for reproducible cancer research.
-
Triterpene Prodrug for Targeted OSCC Therapy
2026-09-13
A 2024 ACS Applied Materials & Interfaces study developed a carrier-free prodrug that combines glycyrrhetinic acid and ginsenoside Rh2 through ROS-responsive thioketal chemistry and rapid solvent-exchange assembly. The design links tumor-associated ROS to drug release and further oxidative amplification, offering a mechanistically coherent strategy for targeted oral squamous cell carcinoma chemotherapy while highlighting the remaining translational questions for natural-product nanomedicines.